腸疾患検査市場：製品、疾患タイプ、診断技術、検査場所別-2025～2030年の世界予測

腸疾患検査市場は、2023年に43億1,000万米ドルと評価され、2024年には45億4,000万米ドルに達すると予測され、CAGR 5.47％で成長し、2030年には62億6,000万米ドルに達すると予測されています。

腸疾患検査の対象範囲には、ウイルス、細菌、寄生虫による消化管内の感染症を特定するための診断法が含まれます。この検査は公衆衛生のモニタリングと臨床管理の両面で極めて重要であり、アウトブレイクを抑制し適切な治療を確保するためのタイムリーな介入を可能にします。用途は広範囲に及び、診断ラボ、病院、クリニック、公衆衛生機関などが含まれます。最終使用セグメントは、患者のケアに重点を置く医療施設から、先進的診断ツールを開発する研究機関まで多岐にわたります。

市場の成長は、病原体の分布に影響を与える世界の旅行者の増加や気候の変化による腸疾患の発生率の上昇などの要因に大きく影響されます。分子診断の技術的進歩や、感染症の早期発見と管理の重要性に対する意識の高まりにより、迅速で正確な診断法に対する需要が高まっています。非侵襲的検査法の革新やポイントオブケア検査キットの開発など、従来の検査インフラが不足している遠隔地や資源の乏しい環境にも対応できる機会が豊富にあります。

しかし、市場は、特に新興国市場において、先進的診断技術に関連する高コストや、先進的機器を操作する熟練者の不足などの限界に直面しています。規制上のハードルも、新しい検査ソリューションの採用を遅らせる要因となっています。新規検査には広範なバリデーションが必要であることや、病原体の表現にばらつきがあることなどの課題が、標準化への取り組みを複雑にしています。

技術革新は、検査の感度と特異性を高めると同時に、コストを削減し、利用しやすさを向上させることに重点を置くべきです。1回の検査で複数の病原体を検出できるマルチプレックスアッセイの調査は特に有望です。さらに、アウトブレイクシナリオでの現場検査用に、携帯可能で使いやすい機器を開発することで、市場開拓の幅を広げることができます。

市場競争は激しいが、ダイナミックな市場であり、現在進行中の研究と技術の進歩によって定義され、さらなる成長の原動力となると同時に、現在の課題への対処も約束されています。戦略的パートナーシップ、合併、買収は、コスト効率の高いソリューションの開発に注力することと共に、この進化する状況下での事業拡大にとって極めて重要です。

市場力学：急速に進化する腸疾患検査市場の主要市場洞察を公開

腸疾患検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 劣悪な衛生環境と汚染された水供給による腸疾患の流行増加
  • 診断検査における技術革新は、より高い感度、特異性、迅速な結果を記載
  • 政府と非政府組織による感染症対策への取り組み
• 市場抑制要因
  • 先進的検査費用の高騰と新興国のインフラ不足
• 市場機会
  • 医療インフラへの投資の増加と予防診断への注力
  • 研究開発活動や市場拡大のための戦略的提携や協力関係
• 市場課題
  • 製品の承認と商業化に関する規制

ポーターのファイブフォース：腸疾患検査市場をナビゲートする戦略ツール

ポーターのファイブフォース：」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：腸疾患検査市場における外部からの影響の把握

外部マクロ環境要因は、腸疾患検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：腸疾患検査市場における競合情勢の把握

腸疾患検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：腸疾患検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、腸疾患検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：腸疾患検査市場における成功への道筋を描く

腸疾患検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 衛生状態の悪さと水質汚染による腸疾患の蔓延
    • 診断検査における技術革新により、感度、特異性が向上し、結果が早く出るようになった
    • 感染症対策に向けた政府・非政府組織の取り組み
  • 抑制要因
    • 新興国における先進的検査の高コストとインフラの不足
  • 機会
    • 医療インフラへの投資の増加と予防診断への重点
    • 研究開発活動と市場拡大のための戦略的パートナーシップとコラボレーション
  • 課題
    • 製品の承認と商品化に関する規制
• 市場セグメンテーション分析
  • 疾患タイプ：細菌検査における多重診断法と分子診断法の採用が増加
  • 検査サイト：病院での即時の患者ケアには迅速な診断が不可欠
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 腸疾患検査市場：製品別

• イントロダクション
• 消耗品
• キット
• 試薬

第7章 腸疾患検査市場：疾患タイプ別

• イントロダクション
• 細菌性
  • コレラ
  • 大腸菌
  • サルモネラ症
• 寄生虫
• ウイルス

第8章 腸疾患検査市場：診断技術別

• イントロダクション
• 免疫測定
• 分子診断
  • PCR
  • リアルタイムPCR
• 迅速診断
  • ディップスティック
  • ラテラルフローアッセイ

第9章 腸疾患検査市場：検査場所別

• イントロダクション
• 病院内
• ポイントオブケア
• 独立ラボ

第10章 南北アメリカの腸疾患検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の腸疾患検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの腸疾患検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • FDAがMeMed BV Directを全血から承認
  • Avacta、欧州の診断検査メーカーを買収
  • Merck、Prometheus Biosciences, Inc.の買収により免疫学パイプラインを強化
• 戦略分析と提言

企業一覧

• 3M Company
• Abbott Laboratories
• Als Limited
• Asure Quality
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Biomerica Inc.
• bioMerieux SA
• Bureau Veritas Group
• Cepheid Inc.
• Coris BioConcept SPRL
• DiaSorin
• Eurofins Scientific SE
• Hardy Diagnostics
• Intertek Group PLC
• Merck & Co., Inc.
• Merck KGAA
• Meridian Bioscience Inc.
• Merieux NutriSciences Corporation
• Neogen Corporation
• Nova Biologicals
• Perkinelmer, Inc.
• Qiagen N.V.
• Quest Diagnostics
• Romer Labs Division Holding GmbH
• SGS SA
• Symbio Laboratories
• Thermo Fisher Scientific Inc.
• Trinity BIoTech PLC
• TUV SUD AG

LIST OF FIGURES

• FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
• FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 58. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 59. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 60. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 61. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 92. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 95. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 96. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 97. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 98. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 99. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 102. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 103. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 104. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 105. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 148. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 155. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 162. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 177. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 184. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 191. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 198. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 205. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 212. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 219. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 220. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 222. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 223. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 224. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 225. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 226. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 233. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 240. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 247. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 248. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 249. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 250. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 251. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 252. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 253. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 254. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 256. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 257. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 258. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 259. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 260. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 261. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 268. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 282. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 289. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 296. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 303. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 310. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 317. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2030 (USD MILLION)
• TABLE 324. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 325. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Enteric Disease Testing Market was valued at USD 4.31 billion in 2023, expected to reach USD 4.54 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 6.26 billion by 2030.

The scope of enteric disease testing encompasses diagnostic methods used to identify infections within the gastrointestinal tract caused by viruses, bacteria, and parasites. This testing is crucial for both public health surveillance and clinical management, enabling timely interventions to control outbreaks and ensure appropriate medical treatment. Applications are widespread and include diagnostic labs, hospitals, clinics, and public health organizations. End-use sectors range from healthcare facilities focusing on patient care to research institutions developing advanced diagnostic tools.

Market growth is significantly influenced by factors such as rising incidence of enteric diseases due to more global travel and changes in climate, which affect pathogen distribution. The demand for rapid, accurate diagnostic methods is increasing, driven by technological advancements in molecular diagnostics and the rising awareness about the importance of early detection and management of infections. Opportunities abound in the innovation of non-invasive testing methods and the development of point-of-care testing kits, which cater to remote or resource-poor settings where traditional lab infrastructure may be lacking.

However, the market faces limitations, including high costs associated with advanced diagnostic technologies and a lack of skilled personnel to operate sophisticated equipment, particularly in developing regions. Regulatory hurdles can also slow the introduction of new testing solutions. Challenges such as the need for extensive validation of novel tests and the variability in pathogen presentation complicate standardization efforts.

Innovation should focus on enhancing the sensitivity and specificity of tests while reducing costs and improving accessibility. Research into multiplex assays capable of detecting multiple pathogens in a single test is particularly promising. Additionally, developing portable, easy-to-use devices for field testing in outbreak scenarios can broaden market reach.

The market is competitive but dynamic, defined by ongoing research and technological progress that promises to address current challenges while driving further growth. Strategic partnerships, mergers, and acquisitions, along with a focus on developing cost-efficient solutions, will be crucial for business expansion in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Enteric Disease Testing Market

The Enteric Disease Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
  • Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
  • Governmental and non-governmental organizations' initiatives to control infectious diseases
• Market Restraints
  • High cost of advanced tests and the lack of infrastructure in emerging countries
• Market Opportunities
  • Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
  • Strategic partnerships and collaborations for R&D activities and market expansion
• Market Challenges
  • Regulations concerning the approval and commercialization of product

Porter's Five Forces: A Strategic Tool for Navigating the Enteric Disease Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Enteric Disease Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Enteric Disease Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Enteric Disease Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Enteric Disease Testing Market

A detailed market share analysis in the Enteric Disease Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Enteric Disease Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Enteric Disease Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Enteric Disease Testing Market

A strategic analysis of the Enteric Disease Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMerieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Merieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TUV SUD AG.

Market Segmentation & Coverage

This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables, Kits, and Reagents.
• Based on Disease Type, market is studied across Bacterial, Parasitic, and Viral. The Bacterial is further studied across Cholera, Escherichia coli, and Salmonellosis.
• Based on Diagnostic Techniques, market is studied across Immunoassays, Molecular Diagnostics, and Rapid Diagnostics. The Molecular Diagnostics is further studied across PCR and Real-time PCR. The Rapid Diagnostics is further studied across Dipsticks and Lateral Flow Assays.
• Based on Testing Site, market is studied across In-Hospital, Point-of-Care, and Standalone Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
    • 5.1.1.2. Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
    • 5.1.1.3. Governmental and non-governmental organizations' initiatives to control infectious diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of advanced tests and the lack of infrastructure in emerging countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
    • 5.1.3.2. Strategic partnerships and collaborations for R&D activities and market expansion
  • 5.1.4. Challenges
    • 5.1.4.1. Regulations concerning the approval and commercialization of product
• 5.2. Market Segmentation Analysis
  • 5.2.1. Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
  • 5.2.2. Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Enteric Disease Testing Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Kits
• 6.4. Reagents

7. Enteric Disease Testing Market, by Disease Type

• 7.1. Introduction
• 7.2. Bacterial
  • 7.2.1. Cholera
  • 7.2.2. Escherichia coli
  • 7.2.3. Salmonellosis
• 7.3. Parasitic
• 7.4. Viral

8. Enteric Disease Testing Market, by Diagnostic Techniques

• 8.1. Introduction
• 8.2. Immunoassays
• 8.3. Molecular Diagnostics
  • 8.3.1. PCR
  • 8.3.2. Real-time PCR
• 8.4. Rapid Diagnostics
  • 8.4.1. Dipsticks
  • 8.4.2. Lateral Flow Assays

9. Enteric Disease Testing Market, by Testing Site

• 9.1. Introduction
• 9.2. In-Hospital
• 9.3. Point-of-Care
• 9.4. Standalone Laboratories

10. Americas Enteric Disease Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Enteric Disease Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Enteric Disease Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. FDA Clears MeMed BV Direct from Whole Blood
  • 13.3.2. Avacta Acquires European Diagnostic Test Maker
  • 13.3.3. Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Als Limited
• 4. Asure Quality
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. Biomerica Inc.
• 8. bioMerieux SA
• 9. Bureau Veritas Group
• 10. Cepheid Inc.
• 11. Coris BioConcept SPRL
• 12. DiaSorin
• 13. Eurofins Scientific SE
• 14. Hardy Diagnostics
• 15. Intertek Group PLC
• 16. Merck & Co., Inc.
• 17. Merck KGAA
• 18. Meridian Bioscience Inc.
• 19. Merieux NutriSciences Corporation
• 20. Neogen Corporation
• 21. Nova Biologicals
• 22. Perkinelmer, Inc.
• 23. Qiagen N.V.
• 24. Quest Diagnostics
• 25. Romer Labs Division Holding GmbH
• 26. SGS SA
• 27. Symbio Laboratories
• 28. Thermo Fisher Scientific Inc.
• 29. Trinity Biotech PLC
• 30. TUV SUD AG